InvestorsHub Logo
Followers 91
Posts 28926
Boards Moderated 2
Alias Born 04/19/2013

Re: WeeZuhl post# 313789

Monday, 04/08/2019 4:20:02 PM

Monday, April 08, 2019 4:20:02 PM

Post# of 403500
Sure thing LOL

After reading all the gaga over Isradipine, that Elite is one of only 2 companies manufacturing it, but dont expect the alleged good news STEADY-III results to impact the share price

Translated: Getting shareholders ready for disappointment

Some may want others to believe everyone in the investment & medical community are ignorant and unable or too lazy to research who may benefit from an Isradipine approval for PD. Utter nonsense!!

The reason for this is to divert attention from the real concern. That being, an Isradipine approval for PD with a meaningful demand for the drug will cause many larger, more seasoned competitors to enter into the market and push Elite into oblivion

So the effort to buy Elite more time (the story of its public life) to generate financial results is the ploy here.. Hopefully the next new Elite BS story will be ready to be told by then

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News